Financing ·
On July 22, 2026, DarioHealth Corp. entered into a Securities Purchase Agreement for a registered direct offering to…
DRIODarioHealth Corp.
On July 22, 2026, DarioHealth Corp. entered into a Securities Purchase Agreement for a registered direct offering to raise approximately $23.5 million in gross proceeds. The offering consists of 2,437,060 shares of common stock priced at $6.80 per share and pre-funded warrants for 1,017,499 shares priced at $6.7999 per warrant. Additionally, board member Dennis Matheis agreed to purchase 14,430 shares at $6.93 per share. The offering is expected to close around July 23, 2026, with proceeds intended for working capital, investments, acquisitions, and general corporate purposes. A.G.P./Alliance Global Partners served as the sole placement agent, receiving a cash fee of 6.0% of gross proceeds, with a 1.0% fee for certain investors. The company operates in the healthcare technology industry, providing an AI-powered platform for managing chronic conditions.